Can we predict when non-targeted systematic prostate biopsies need to be performed? Outcomes from the multicentre RAPIDOnline 3,853 patient cohort
Impact of peritoneal bladder flap on the risk of lymphoceles after robotic radical prostatectomy: Results of a prospective controlled trial
Does lymph node dissection improve the prognosis of patients undergoing radical prostatectomy? Results of the MICAN study
Adverse pathology of prostate cancer after radical prostatectomy. Summary after 7 years and 1500 patients since introduction of mpMRI-guided biopsy in a real world setting
Can intraoperative nerve monitoring improve functional outcomes after unilateral- or non-nerve-sparing robot-assisted radical prostatectomy – a randomized clinical trial
Outcomes of grade group 2 and 3 prostate cancer on initial versus confirmatory biopsy: Implications for active surveillance
European Urology Focus, December 2023
Oncologic outcomes of patients with lymph node invasion at prostatectomy and post-prostatectomy biochemical persistence
Urologic Oncology: Seminars and Original Investigations, November 2022
Prostate cancer mortality rates in low- and favorable intermediate-risk active surveillance patients: a population-based competing risks analysis
World Journal of Urology, December 2022
Family history of prostate cancer and survival outcomes in the UK genetic prostate cancer study
European Urology, December 2022
Prostate cancer screening with PSA and MRI followed by targeted biopsy only
The New England Journal of Medicine, December 2022
Confocal laser microscopy for assessment of surgical margins during radical prostatectomy
BJU International 2022 Dec 06, November 2022
Shifting risk-stratified early prostate cancer detection to a primary healthcare setting
BJU international, November 2022
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy. I agree Read More